Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
| DrugCom Name |
DrugCom ID |
Component Drug |
Indication |
REF |
|
1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole + Triapine
|
DCE3NJ1
|
1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
10-hydroxycamptothecin + Triapine
|
DC5GREU
|
10-hydroxycamptothecin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
10-hydroxycamptothecin + Triapine
|
DC8HUWL
|
10-hydroxycamptothecin
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[3] |
|
Abacavir + Triapine
|
DC9705Q
|
Abacavir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
ABIRATERONE + Triapine
|
DCJHL9G
|
ABIRATERONE
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[3] |
|
ABIRATERONE + Triapine
|
DCUY7P4
|
ABIRATERONE
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)
|
[3] |
|
ABIRATERONE + Triapine
|
DCEFH4Z
|
ABIRATERONE
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
ABIRATERONE + Triapine
|
DCWNJP7
|
ABIRATERONE
|
Melanoma (Cell Line: SK-MEL-2)
|
[3] |
|
Acamprosate + Triapine
|
DCNPE2Y
|
Acamprosate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Acetazolamide + Triapine
|
DCZR1SC
|
Acetazolamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Acitretin + Triapine
|
DCS33OL
|
Acitretin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Albendazole + Triapine
|
DCDRN8G
|
Albendazole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Aliskiren + Triapine
|
DC9WBBG
|
Aliskiren
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Amiloride + Triapine
|
DCFZO3Q
|
Amiloride
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Amodiaquine + Triapine
|
DCWK62E
|
Amodiaquine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Amonafide + Triapine
|
DC11F50
|
Amonafide
|
Adenocarcinoma (Cell Line: NCIH23)
|
[2] |
|
Amonafide + Triapine
|
DCYYEQR
|
Amonafide
|
Adenocarcinoma (Cell Line: A549)
|
[2] |
|
Amonafide + Triapine
|
DCWCNLL
|
Amonafide
|
Adenocarcinoma (Cell Line: SW-620)
|
[2] |
|
Amonafide + Triapine
|
DCDH70M
|
Amonafide
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Amonafide + Triapine
|
DCTJUF2
|
Amonafide
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Amonafide + Triapine
|
DCOHW11
|
Amonafide
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[2] |
|
Amonafide + Triapine
|
DC73HSD
|
Amonafide
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[2] |
|
Amonafide + Triapine
|
DC3B45C
|
Amonafide
|
Clear cell renal cell carcinoma (Cell Line: CAKI-1)
|
[2] |
|
Amonafide + Triapine
|
DCPG3DT
|
Amonafide
|
Glioma (Cell Line: SF-268)
|
[2] |
|
Amonafide + Triapine
|
DCQOHC3
|
Amonafide
|
Glioma (Cell Line: SF-539)
|
[2] |
|
Amonafide + Triapine
|
DCYW2H2
|
Amonafide
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[2] |
|
Amonafide + Triapine
|
DCYPUON
|
Amonafide
|
Non-small cell lung carcinoma (Cell Line: HOP-92)
|
[2] |
|
Amonafide + Triapine
|
DCMRT5G
|
Amonafide
|
Carcinoma (Cell Line: MCF7)
|
[4] |
|
Amonafide + Triapine
|
DCFV8VG
|
Amonafide
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
Anamorelin + Triapine
|
DC8IC3C
|
Anamorelin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Anastrozole + Triapine
|
DCU8F7U
|
Anastrozole
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
|
Anastrozole + Triapine
|
DCZIUTK
|
Anastrozole
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
|
Armodafinil + Triapine
|
DCIULMF
|
Armodafinil
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
AS-1949490 + Triapine
|
DC6ODF7
|
AS-1949490
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Asenapine + Triapine
|
DCIUQGZ
|
Asenapine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Atenolol + Triapine
|
DC3E6XT
|
Atenolol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Azacitidine + Triapine
|
DCUP953
|
Azacitidine
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[2] |
|
Azatadine + Triapine
|
DCF09UC
|
Azatadine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
BIO-300 + Triapine
|
DC81IF5
|
BIO-300
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
BIO-300 + Triapine
|
DCZQF4S
|
BIO-300
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[2] |
|
BIO-300 + Triapine
|
DCZ0ID1
|
BIO-300
|
Clear cell renal cell carcinoma (Cell Line: CAKI-1)
|
[2] |
|
BIO-300 + Triapine
|
DCVWHZU
|
BIO-300
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[2] |
|
BIO-300 + Triapine
|
DCXEIWM
|
BIO-300
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[4] |
|
BIO-300 + Triapine
|
DCUIYU8
|
BIO-300
|
Carcinoma (Cell Line: RXF 393)
|
[4] |
|
BIO-300 + Triapine
|
DCZB2LH
|
BIO-300
|
Carcinoma (Cell Line: MCF7)
|
[4] |
|
BIO-300 + Triapine
|
DCUI8WP
|
BIO-300
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
BIO-300 + Triapine
|
DCVE6FS
|
BIO-300
|
Adenocarcinoma (Cell Line: DU-145)
|
[3] |
|
BIO-300 + Triapine
|
DCPVFSW
|
BIO-300
|
Adenocarcinoma (Cell Line: SW-620)
|
[3] |
|
BIO-300 + Triapine
|
DC2P7ZH
|
BIO-300
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)
|
[3] |
|
BIO-300 + Triapine
|
DCFDNOR
|
BIO-300
|
Lung adenocarcinoma (Cell Line: MDA-MB-231)
|
[3] |
|
BIO-300 + Triapine
|
DCWJSDT
|
BIO-300
|
Non-small cell lung carcinoma (Cell Line: HOP-92)
|
[3] |
|
BIO-300 + Triapine
|
DCRC62Y
|
BIO-300
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[3] |
|
Bosentan + Triapine
|
DCDG949
|
Bosentan
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
BRL-15572 + Triapine
|
DCME1CI
|
BRL-15572
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Busulfan + Triapine
|
DC28H1P
|
Busulfan
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Cabazitaxel + Triapine
|
DC9S5AU
|
Cabazitaxel
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
|
Chlormezanone + Triapine
|
DCPDJ8J
|
Chlormezanone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Cilastatin + Triapine
|
DCYARBX
|
Cilastatin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Ciprofibrate + Triapine
|
DCUNDJ6
|
Ciprofibrate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Cisatracurium + Triapine
|
DCIXNFK
|
Cisatracurium
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Citalopram + Triapine
|
DCZGBO5
|
Citalopram
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Clascoterone + Triapine
|
DCX40MA
|
Clascoterone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Clindamycin + Triapine
|
DCUREVL
|
Clindamycin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Clopidogrel + Triapine
|
DC9DQ0P
|
Clopidogrel
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Crizotinib + Triapine
|
DCG38GN
|
Crizotinib
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[2] |
|
Crizotinib + Triapine
|
DC8J5HW
|
Crizotinib
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[2] |
|
Crotamiton + Triapine
|
DCJ21AH
|
Crotamiton
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Dacarbazine + Triapine
|
DCZY3A6
|
Dacarbazine
|
Lung adenocarcinoma (Cell Line: MDA-MB-231)
|
[2] |
|
Dactinomycin + Triapine
|
DCDEX0D
|
Dactinomycin
|
Adenocarcinoma (Cell Line: DU-145)
|
[3] |
|
Dactinomycin + Triapine
|
DCNY4WB
|
Dactinomycin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Dactinomycin + Triapine
|
DCWHDQQ
|
Dactinomycin
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[3] |
|
Daidzin + Triapine
|
DCEP465
|
Daidzin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Dasatinib + Triapine
|
DCWPOPN
|
Dasatinib
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Dasatinib + Triapine
|
DC592YL
|
Dasatinib
|
Astrocytoma (Cell Line: U251)
|
[2] |
|
Desoxycorticosterone pivalate + Triapine
|
DCZTAY0
|
Desoxycorticosterone pivalate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Dexrazoxane + Triapine
|
DC6I5KA
|
Dexrazoxane
|
Clear cell renal cell carcinoma (Cell Line: CAKI-1)
|
[2] |
|
Dexrazoxane + Triapine
|
DCULCHQ
|
Dexrazoxane
|
Adenocarcinoma (Cell Line: HCC-2998)
|
[3] |
|
DFN-15 + Triapine
|
DCVYL6J
|
DFN-15
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[2] |
|
DFN-15 + Triapine
|
DCCGHSA
|
DFN-15
|
Carcinoma (Cell Line: RXF 393)
|
[4] |
|
DFN-15 + Triapine
|
DC3DNKP
|
DFN-15
|
Melanoma (Cell Line: SK-MEL-2)
|
[3] |
|
Diethylcarbamazine + Triapine
|
DCR48IO
|
Diethylcarbamazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Digitoxin + Triapine
|
DCYRXOV
|
Digitoxin
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Diphenidol + Triapine
|
DC8DTWI
|
Diphenidol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Docetaxel + Triapine
|
DCO4X1U
|
Docetaxel
|
Adenocarcinoma (Cell Line: DU-145)
|
[2] |
|
Docetaxel + Triapine
|
DCK9ME9
|
Docetaxel
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Docetaxel + Triapine
|
DCKV0GV
|
Docetaxel
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[2] |
|
Docetaxel + Triapine
|
DCO63B7
|
Docetaxel
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[2] |
|
Docetaxel + Triapine
|
DC6DI3U
|
Docetaxel
|
Cutaneous melanoma (Cell Line: SK-MEL-28)
|
[2] |
|
Docetaxel + Triapine
|
DC8R96W
|
Docetaxel
|
Glioma (Cell Line: SF-539)
|
[2] |
|
Docetaxel + Triapine
|
DC8D1US
|
Docetaxel
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)
|
[2] |
|
Docetaxel + Triapine
|
DC6JE2A
|
Docetaxel
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[2] |
|
Docetaxel + Triapine
|
DC65ABI
|
Docetaxel
|
Lung adenocarcinoma (Cell Line: MDA-MB-231)
|
[2] |
|
Docetaxel + Triapine
|
DCQBJR7
|
Docetaxel
|
Malignant melanoma (Cell Line: UACC62)
|
[2] |
|
Docetaxel + Triapine
|
DCGZ3XB
|
Docetaxel
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[2] |
|
Docetaxel + Triapine
|
DC1CUMN
|
Docetaxel
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[2] |
|
Docetaxel + Triapine
|
DCAQ9DV
|
Docetaxel
|
Colon carcinoma (Cell Line: KM12)
|
[4] |
|
Docetaxel + Triapine
|
DCJSWTU
|
Docetaxel
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
Dopamine + Triapine
|
DCWYF3L
|
Dopamine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Dronedarone + Triapine
|
DCL55HR
|
Dronedarone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Enalaprilat + Triapine
|
DCGU9JM
|
Enalaprilat
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Endoxifen + Triapine
|
DCANA7B
|
Endoxifen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Enoxacin + Triapine
|
DCBX6IG
|
Enoxacin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Epirubicin + Triapine
|
DCMQ7B1
|
Epirubicin
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Epirubicin + Triapine
|
DCYAJ2B
|
Epirubicin
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[3] |
|
Epirubicin + Triapine
|
DCMOY52
|
Epirubicin
|
Adenocarcinoma (Cell Line: HCT-15)
|
[3] |
|
Epirubicin + Triapine
|
DCY16WX
|
Epirubicin
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[3] |
|
Epirubicin + Triapine
|
DCU38LP
|
Epirubicin
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[3] |
|
Eptifibatide + Triapine
|
DC9P5FD
|
Eptifibatide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Estramustine + Triapine
|
DCTGKS6
|
Estramustine
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[2] |
|
Estramustine + Triapine
|
DCBOLAN
|
Estramustine
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[2] |
|
Estramustine + Triapine
|
DCA1KTZ
|
Estramustine
|
Clear cell renal cell carcinoma (Cell Line: CAKI-1)
|
[2] |
|
Estramustine + Triapine
|
DCDZ98U
|
Estramustine
|
Adenocarcinoma (Cell Line: HCT116)
|
[3] |
|
Ethinyl estradiol + Triapine
|
DCO5YI9
|
Ethinyl estradiol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Etonogestrel + Triapine
|
DCYAIGX
|
Etonogestrel
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Fenoprofen + Triapine
|
DCTKGA1
|
Fenoprofen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Fibrates + Triapine
|
DCI7QQ4
|
Fibrates
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Fludarabine + Triapine
|
DCROOSU
|
Fludarabine
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[3] |
|
Fludarabine + Triapine
|
DC46L54
|
Fludarabine
|
Prostate carcinoma (Cell Line: PC-3)
|
[3] |
|
Fomepizole + Triapine
|
DCIZTEU
|
Fomepizole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
FORMESTANE + Triapine
|
DC9TIOD
|
FORMESTANE
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Gefitinib + Triapine
|
DCMTH5D
|
Gefitinib
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
|
Gefitinib + Triapine
|
DC4B246
|
Gefitinib
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)
|
[2] |
|
GINKGOLIDE A + Triapine
|
DCN2VOB
|
GINKGOLIDE A
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Hydralazine + Triapine
|
DCKNRBS
|
Hydralazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Idarubicin + Triapine
|
DCE2SV3
|
Idarubicin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Idarubicin + Triapine
|
DCDBFRW
|
Idarubicin
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[2] |
|
Idarubicin + Triapine
|
DCT837I
|
Idarubicin
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[2] |
|
Idarubicin + Triapine
|
DC7VH8E
|
Idarubicin
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[2] |
|
Idarubicin + Triapine
|
DC08HWP
|
Idarubicin
|
Carcinoma (Cell Line: MCF7)
|
[4] |
|
Idarubicin + Triapine
|
DCADJ4N
|
Idarubicin
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
Idarubicin + Triapine
|
DCAZSAH
|
Idarubicin
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[3] |
|
Idarubicin + Triapine
|
DC8NWEW
|
Idarubicin
|
Adenocarcinoma (Cell Line: HCT116)
|
[3] |
|
Idarubicin + Triapine
|
DCR4909
|
Idarubicin
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)
|
[3] |
|
Imatinib + Triapine
|
DC9I9P4
|
Imatinib
|
Adenocarcinoma (Cell Line: HCT116)
|
[2] |
|
Imatinib + Triapine
|
DCU0JBH
|
Imatinib
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[2] |
|
Imatinib + Triapine
|
DC7XODB
|
Imatinib
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)
|
[2] |
|
Imatinib + Triapine
|
DC156UT
|
Imatinib
|
Carcinoma (Cell Line: RXF 393)
|
[4] |
|
Indazole derivative 5 + Triapine
|
DC7J5U4
|
Indazole derivative 5
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[3] |
|
Indazole derivative 5 + Triapine
|
DCF4KKK
|
Indazole derivative 5
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)
|
[3] |
|
Indazole derivative 5 + Triapine
|
DCPIDXI
|
Indazole derivative 5
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
Indazole derivative 5 + Triapine
|
DC2HOH6
|
Indazole derivative 5
|
Melanoma (Cell Line: SK-MEL-2)
|
[3] |
|
Itraconazole + Triapine
|
DCYOGN3
|
Itraconazole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Lacosamide + Triapine
|
DCVQM6A
|
Lacosamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Lapatinib + Triapine
|
DCXXWIK
|
Lapatinib
|
Carcinoma (Cell Line: RXF 393)
|
[4] |
|
Lapatinib + Triapine
|
DCBZ3OI
|
Lapatinib
|
Adenocarcinoma (Cell Line: DU-145)
|
[3] |
|
Lapatinib + Triapine
|
DCWKW4S
|
Lapatinib
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[3] |
|
Lapatinib + Triapine
|
DCOFI5E
|
Lapatinib
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[3] |
|
Lapatinib + Triapine
|
DCHHBM1
|
Lapatinib
|
Astrocytoma (Cell Line: U251)
|
[3] |
|
Lapatinib + Triapine
|
DCBUDLX
|
Lapatinib
|
Cutaneous melanoma (Cell Line: SK-MEL-28)
|
[3] |
|
Lapatinib + Triapine
|
DCUN5DA
|
Lapatinib
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[3] |
|
Lapatinib + Triapine
|
DCFSL6P
|
Lapatinib
|
Glioma (Cell Line: SF-268)
|
[3] |
|
Lapatinib + Triapine
|
DCYQ8UP
|
Lapatinib
|
Malignant melanoma (Cell Line: UACC62)
|
[3] |
|
Lapatinib + Triapine
|
DCMSBHG
|
Lapatinib
|
Melanoma (Cell Line: UACC-257)
|
[3] |
|
Lapatinib + Triapine
|
DCKIIYA
|
Lapatinib
|
Non-small cell lung carcinoma (Cell Line: HOP-92)
|
[3] |
|
Lefaxin + Triapine
|
DCHX11J
|
Lefaxin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Leflunomide + Triapine
|
DCHFBYA
|
Leflunomide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Lenalidomide + Triapine
|
DC9HE87
|
Lenalidomide
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[4] |
|
Lenalidomide + Triapine
|
DCVVVHD
|
Lenalidomide
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
Lenalidomide + Triapine
|
DCB5UGS
|
Lenalidomide
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[3] |
|
Lenalidomide + Triapine
|
DC4Q1IY
|
Lenalidomide
|
Cutaneous melanoma (Cell Line: SK-MEL-28)
|
[3] |
|
Lenalidomide + Triapine
|
DCON37T
|
Lenalidomide
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[3] |
|
Letrozole + Triapine
|
DCAUN1H
|
Letrozole
|
Adenocarcinoma (Cell Line: DU-145)
|
[2] |
|
Letrozole + Triapine
|
DC14VA4
|
Letrozole
|
Adenocarcinoma (Cell Line: HCT116)
|
[2] |
|
Letrozole + Triapine
|
DC4W88J
|
Letrozole
|
Astrocytoma (Cell Line: U251)
|
[2] |
|
Letrozole + Triapine
|
DCOYDMO
|
Letrozole
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[2] |
|
Letrozole + Triapine
|
DCJH0HP
|
Letrozole
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)
|
[2] |
|
Letrozole + Triapine
|
DCXZTNU
|
Letrozole
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[2] |
|
Letrozole + Triapine
|
DCHMW55
|
Letrozole
|
Melanoma (Cell Line: MALME-3M)
|
[2] |
|
Letrozole + Triapine
|
DC4VSDM
|
Letrozole
|
Non-small cell lung carcinoma (Cell Line: HOP-92)
|
[2] |
|
Letrozole + Triapine
|
DCN9OGM
|
Letrozole
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
LIAROZOLE + Triapine
|
DC6E069
|
LIAROZOLE
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Loperamide + Triapine
|
DCQI568
|
Loperamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Lubiprostone + Triapine
|
DC75X39
|
Lubiprostone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Maprotiline + Triapine
|
DCN2KF1
|
Maprotiline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Maraviroc + Triapine
|
DC483TJ
|
Maraviroc
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Mechlorethamine + Triapine
|
DC7KHPQ
|
Mechlorethamine
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
|
Mechlorethamine + Triapine
|
DC3B4H5
|
Mechlorethamine
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[2] |
|
Mechlorethamine + Triapine
|
DCE2WAM
|
Mechlorethamine
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[3] |
|
Metaxalone + Triapine
|
DCS0IYT
|
Metaxalone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Metformin + Triapine
|
DCGUW3M
|
Metformin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Methoxsalen + Triapine
|
DC7W9QG
|
Methoxsalen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Methylergonovine + Triapine
|
DC6T8Q3
|
Methylergonovine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Miglustat + Triapine
|
DCVMQAD
|
Miglustat
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Mycophenolic acid + Triapine
|
DCYQ6ZQ
|
Mycophenolic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Olanzapine + Triapine
|
DCE5I22
|
Olanzapine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Oseltamivir + Triapine
|
DCFD5UL
|
Oseltamivir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Oxandrolone + Triapine
|
DCCS19W
|
Oxandrolone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Paromomycin + Triapine
|
DC4G69W
|
Paromomycin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Pentamidine + Triapine
|
DCCHMSP
|
Pentamidine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
PF-02545920 + Triapine
|
DCPP87K
|
PF-02545920
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Phensuximide + Triapine
|
DC6ZIK3
|
Phensuximide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Picoplatin + Triapine
|
DC7B0LF
|
Picoplatin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Picoplatin + Triapine
|
DCIW6L0
|
Picoplatin
|
Glioblastoma (Cell Line: SNB-75)
|
[2] |
|
Pizotyline + Triapine
|
DCA1TZA
|
Pizotyline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Plicamycin + Triapine
|
DC5W4O1
|
Plicamycin
|
Adenocarcinoma (Cell Line: HCC-2998)
|
[3] |
|
Plicamycin + Triapine
|
DCO6O80
|
Plicamycin
|
Malignant melanoma (Cell Line: UACC62)
|
[3] |
|
PMID28460551-Compound-2 + Triapine
|
DCY0ADX
|
PMID28460551-Compound-2
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
PMID28460551-Compound-2 + Triapine
|
DCXKOL1
|
PMID28460551-Compound-2
|
Adenocarcinoma (Cell Line: HCT-15)
|
[3] |
|
Pramipexole + Triapine
|
DCH8QJY
|
Pramipexole
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Probenecid + Triapine
|
DCIB796
|
Probenecid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Quinine + Triapine
|
DCL5ZQI
|
Quinine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Raloxifene + Triapine
|
DCAMQ8S
|
Raloxifene
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[2] |
|
Raloxifene + Triapine
|
DCMXBQZ
|
Raloxifene
|
Glioma (Cell Line: SF-268)
|
[2] |
|
Raloxifene + Triapine
|
DCY4SMU
|
Raloxifene
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[4] |
|
Raloxifene + Triapine
|
DCZ5QOS
|
Raloxifene
|
Adenocarcinoma (Cell Line: DU-145)
|
[3] |
|
Raloxifene + Triapine
|
DCUOD3T
|
Raloxifene
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[3] |
|
Raloxifene + Triapine
|
DCL7LGQ
|
Raloxifene
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[3] |
|
Raloxifene + Triapine
|
DCV8XZW
|
Raloxifene
|
Melanoma (Cell Line: SK-MEL-2)
|
[3] |
|
Raloxifene + Triapine
|
DCC9F9K
|
Raloxifene
|
Melanoma (Cell Line: MALME-3M)
|
[3] |
|
Raloxifene + Triapine
|
DCE3CBN
|
Raloxifene
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[3] |
|
Raltegravir + Triapine
|
DCJ7844
|
Raltegravir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Ramelteon + Triapine
|
DCZEG0I
|
Ramelteon
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Rifampin + Triapine
|
DCC0HK6
|
Rifampin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Romidepsin + Triapine
|
DCOG482
|
Romidepsin
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[3] |
|
Romidepsin + Triapine
|
DCN09A8
|
Romidepsin
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[3] |
|
Rufinamide + Triapine
|
DCM7IX4
|
Rufinamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Ruxolitinib + Triapine
|
DCGV4F8
|
Ruxolitinib
|
Glioma (Cell Line: SF-268)
|
[2] |
|
Ruxolitinib + Triapine
|
DC6GTPF
|
Ruxolitinib
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
Ruxolitinib + Triapine
|
DCTVLED
|
Ruxolitinib
|
Adenocarcinoma (Cell Line: HCT-15)
|
[3] |
|
Ruxolitinib + Triapine
|
DCF2K43
|
Ruxolitinib
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[3] |
|
Ruxolitinib + Triapine
|
DCQ19CT
|
Ruxolitinib
|
Melanoma (Cell Line: SK-MEL-2)
|
[3] |
|
SCH 727965 + Triapine
|
DCPNE7X
|
SCH 727965
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
SCH 727965 + Triapine
|
DCQ0X6B
|
SCH 727965
|
Clear cell renal cell carcinoma (Cell Line: A498)
|
[2] |
|
SCH 727965 + Triapine
|
DCMTEWP
|
SCH 727965
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[4] |
|
SCH 727965 + Triapine
|
DCC47B5
|
SCH 727965
|
Adenocarcinoma (Cell Line: DU-145)
|
[3] |
|
SCH 727965 + Triapine
|
DC0LXEE
|
SCH 727965
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[3] |
|
Spironolactone + Triapine
|
DCH6DRB
|
Spironolactone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Sumatriptan + Triapine
|
DCH2JSR
|
Sumatriptan
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
SY-1425 + Triapine
|
DCB5W11
|
SY-1425
|
Clear cell renal cell carcinoma (Cell Line: CAKI-1)
|
[2] |
|
SY-1425 + Triapine
|
DCQ8PEN
|
SY-1425
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[2] |
|
SY-1425 + Triapine
|
DCX8AJH
|
SY-1425
|
Carcinoma (Cell Line: RXF 393)
|
[4] |
|
SY-1425 + Triapine
|
DC9P5VQ
|
SY-1425
|
Adenocarcinoma (Cell Line: HCT116)
|
[3] |
|
SY-1425 + Triapine
|
DCT082D
|
SY-1425
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[3] |
|
SY-1425 + Triapine
|
DCEYXXH
|
SY-1425
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)
|
[3] |
|
SY-1425 + Triapine
|
DC5S843
|
SY-1425
|
Melanoma (Cell Line: SK-MEL-2)
|
[3] |
|
SY-1425 + Triapine
|
DCZZVM5
|
SY-1425
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[3] |
|
Tacrine + Triapine
|
DCB3B30
|
Tacrine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Tacrolimus + Triapine
|
DCLRCYF
|
Tacrolimus
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Tamoxifen + Triapine
|
DCH88ZO
|
Tamoxifen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Taxol + Triapine
|
DC9EQTZ
|
Taxol
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[2] |
|
Taxol + Triapine
|
DCS5AQF
|
Taxol
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
|
Taxol + Triapine
|
DCBYPD1
|
Taxol
|
Prostate carcinoma (Cell Line: PC-3)
|
[3] |
|
TEM + Triapine
|
DC66VY4
|
TEM
|
Astrocytoma (Cell Line: U251)
|
[2] |
|
TEM + Triapine
|
DCCX209
|
TEM
|
Clear cell renal cell carcinoma (Cell Line: A498)
|
[2] |
|
TEM + Triapine
|
DC36C95
|
TEM
|
Glioblastoma (Cell Line: SNB-75)
|
[2] |
|
TEM + Triapine
|
DCBRF1B
|
TEM
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
|
TEM + Triapine
|
DCWB9VU
|
TEM
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[4] |
|
TEM + Triapine
|
DCETXQ5
|
TEM
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
TEM + Triapine
|
DCH5LY8
|
TEM
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[3] |
|
TEM + Triapine
|
DCTI9PD
|
TEM
|
Adenocarcinoma (Cell Line: A549)
|
[3] |
|
TEM + Triapine
|
DC3GGAO
|
TEM
|
Adenocarcinoma (Cell Line: HCC-2998)
|
[3] |
|
TEM + Triapine
|
DCH36GV
|
TEM
|
Adenocarcinoma (Cell Line: HCT116)
|
[3] |
|
TEM + Triapine
|
DCXH4UQ
|
TEM
|
Adenocarcinoma (Cell Line: HCT-15)
|
[3] |
|
TEM + Triapine
|
DCO7ICO
|
TEM
|
Melanoma (Cell Line: MALME-3M)
|
[3] |
|
TEM + Triapine
|
DCCNG2S
|
TEM
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[3] |
|
TEM + Triapine
|
DC9N4RH
|
TEM
|
Prostate carcinoma (Cell Line: PC-3)
|
[3] |
|
Terazosin + Triapine
|
DC6OZ60
|
Terazosin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Testolactone + Triapine
|
DCOLF3J
|
Testolactone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Testosterone + Triapine
|
DCTN6SJ
|
Testosterone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Tiagabine + Triapine
|
DC5MVIQ
|
Tiagabine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Tindamax + Triapine
|
DCEKE15
|
Tindamax
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Tolazoline + Triapine
|
DC5HY07
|
Tolazoline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Tolvaptan + Triapine
|
DCU2EWP
|
Tolvaptan
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Topotecan + Triapine
|
DCFQ8Q4
|
Topotecan
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[4] |
|
Topotecan + Triapine
|
DCQ768P
|
Topotecan
|
Carcinoma (Cell Line: MCF7)
|
[4] |
|
Topotecan + Triapine
|
DCUBVJ8
|
Topotecan
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[3] |
|
Topotecan + Triapine
|
DCPK6Z9
|
Topotecan
|
Clear cell renal cell carcinoma (Cell Line: CAKI-1)
|
[3] |
|
Topotecan + Triapine
|
DCDDHAM
|
Topotecan
|
Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)
|
[3] |
|
Topotecan + Triapine
|
DCQ8BZU
|
Topotecan
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[3] |
|
Topotecan + Triapine
|
DC56P2N
|
Topotecan
|
Pleural epithelioid mesothelioma (Cell Line: NCI-H226)
|
[3] |
|
Triamterene + Triapine
|
DCN1B8X
|
Triamterene
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Triapine + Pentostatin
|
DCAFSIZ
|
Pentostatin
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
Triapine + Fulvestrant
|
DCXUHHO
|
Fulvestrant
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
Triapine + Ixabepilone
|
DC3EDCE
|
Ixabepilone
|
Colon carcinoma (Cell Line: KM12)
|
[4] |
|
Triapine + Methotrexate
|
DC99S4S
|
Methotrexate
|
Colon carcinoma (Cell Line: KM12)
|
[4] |
|
Triapine + Isoniazid
|
DCNBUZ3
|
Isoniazid
|
Colon carcinoma (Cell Line: KM12)
|
[4] |
|
Triapine + Plicamycin
|
DCFSTII
|
Plicamycin
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
|
Triapine + Pralatrexate
|
DCGB3QB
|
Pralatrexate
|
Carcinoma (Cell Line: MCF7)
|
[4] |
|
Triapine + Ifosfamide
|
DC4LPBJ
|
Ifosfamide
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[4] |
|
Triapine + Raloxifene
|
DC83WGN
|
Raloxifene
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
Triapine + Sirolimus
|
DCRGVLE
|
Sirolimus
|
Carcinoma (Cell Line: RXF 393)
|
[4] |
|
Triapine + Valrubicin
|
DC92ZLO
|
Valrubicin
|
Colon carcinoma (Cell Line: KM12)
|
[4] |
|
Triapine + Chlorambucil
|
DCL8CM6
|
Chlorambucil
|
Colon adenocarcinoma (Cell Line: COLO 205)
|
[4] |
|
Triapine + ER819762
|
DCKC356
|
ER819762
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[4] |
|
Triapine + Pomalidomide
|
DCX6ZT8
|
Pomalidomide
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
Triapine + Vinflunine
|
DC1X7QR
|
Vinflunine
|
Carcinoma (Cell Line: MCF7)
|
[4] |
|
Triapine + Vinflunine
|
DCDXQB0
|
Vinflunine
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
Triapine + Mepacrine
|
DC6JOMK
|
Mepacrine
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
Triapine + PMID28870136-Compound-43
|
DC4DC1X
|
PMID28870136-Compound-43
|
Carcinoma (Cell Line: RXF 393)
|
[4] |
|
Triapine + FORMESTANE
|
DC9W1C0
|
FORMESTANE
|
Colon carcinoma (Cell Line: KM12)
|
[4] |
|
Triapine + FORMESTANE
|
DCZ4GDU
|
FORMESTANE
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[4] |
|
Triapine + Busulfan
|
DC0128H
|
Busulfan
|
Invasive ductal carcinoma (Cell Line: T-47D)
|
[4] |
|
Triapine + Aprepitant
|
DC0TOD9
|
Aprepitant
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Sertraline
|
DCUXRT8
|
Sertraline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Pentostatin
|
DCJYQ2Y
|
Pentostatin
|
Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)
|
[3] |
|
Triapine + Pentostatin
|
DCE3IFG
|
Pentostatin
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
|
Triapine + Pentostatin
|
DC3R7XO
|
Pentostatin
|
Astrocytoma (Cell Line: U251)
|
[3] |
|
Triapine + Pentostatin
|
DCBM6U9
|
Pentostatin
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[3] |
|
Triapine + Pentostatin
|
DC60K25
|
Pentostatin
|
Renal cell carcinoma (Cell Line: UO-31)
|
[3] |
|
Triapine + Mebutamate
|
DCHKZWG
|
Mebutamate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Primidone
|
DCWCVV5
|
Primidone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Fulvestrant
|
DC7B93F
|
Fulvestrant
|
Clear cell renal cell carcinoma (Cell Line: A498)
|
[3] |
|
Triapine + Fulvestrant
|
DCIH9FK
|
Fulvestrant
|
Glioblastoma (Cell Line: SNB-75)
|
[3] |
|
Triapine + Fulvestrant
|
DC3GYHI
|
Fulvestrant
|
Lung adenocarcinoma (Cell Line: MDA-MB-231)
|
[3] |
|
Triapine + Gefitinib
|
DCCIQ12
|
Gefitinib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Diethylcarbamazine
|
DCIZTRK
|
Diethylcarbamazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Hepzato
|
DC2FL9A
|
Hepzato
|
Adenocarcinoma (Cell Line: DU-145)
|
[3] |
|
Triapine + Hepzato
|
DC9JM0Q
|
Hepzato
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[3] |
|
Triapine + Hepzato
|
DCOJ54M
|
Hepzato
|
Astrocytoma (Cell Line: U251)
|
[3] |
|
Triapine + Hepzato
|
DC9YYR5
|
Hepzato
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[3] |
|
Triapine + Hepzato
|
DCK0ICA
|
Hepzato
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[3] |
|
Triapine + Citalopram
|
DCQUTM9
|
Citalopram
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Imipramine
|
DCKNSI1
|
Imipramine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Dactinomycin
|
DCONXFS
|
Dactinomycin
|
Adenocarcinoma (Cell Line: HCC-2998)
|
[3] |
|
Triapine + Cyclophosphamide
|
DCLN1HN
|
Cyclophosphamide
|
Adenocarcinoma (Cell Line: DU-145)
|
[3] |
|
Triapine + Cyclophosphamide
|
DCJCUPK
|
Cyclophosphamide
|
Amelanotic melanoma (Cell Line: M14)
|
[3] |
|
Triapine + Cyclophosphamide
|
DCFPCTN
|
Cyclophosphamide
|
Glioma (Cell Line: SF-268)
|
[3] |
|
Triapine + Cyclophosphamide
|
DC7FN6U
|
Cyclophosphamide
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
Triapine + Trioxsalen
|
DCXBJNN
|
Trioxsalen
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Isoniazid
|
DCTGQB0
|
Isoniazid
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[3] |
|
Triapine + Isoniazid
|
DCMGN94
|
Isoniazid
|
Glioma (Cell Line: SF-539)
|
[3] |
|
Triapine + Isoniazid
|
DCM8MT5
|
Isoniazid
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[3] |
|
Triapine + Isoniazid
|
DCWQK8V
|
Isoniazid
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
Triapine + Isoniazid
|
DCFP78M
|
Isoniazid
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[3] |
|
Triapine + Isoniazid
|
DCNK7V7
|
Isoniazid
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[3] |
|
Triapine + Isoniazid
|
DCMW4DW
|
Isoniazid
|
Prostate carcinoma (Cell Line: PC-3)
|
[3] |
|
Triapine + Vinblastine
|
DCK8CZG
|
Vinblastine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Pazopanib HCl
|
DC3VPRX
|
Pazopanib HCl
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Ezetimibe
|
DCSI221
|
Ezetimibe
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Plicamycin
|
DCHGVTS
|
Plicamycin
|
Adenocarcinoma (Cell Line: A549)
|
[3] |
|
Triapine + Plicamycin
|
DCMS7SF
|
Plicamycin
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[3] |
|
Triapine + Plicamycin
|
DCGRKRJ
|
Plicamycin
|
Cutaneous melanoma (Cell Line: SK-MEL-28)
|
[3] |
|
Triapine + Plicamycin
|
DCBW9UE
|
Plicamycin
|
Glioblastoma (Cell Line: SNB-75)
|
[3] |
|
Triapine + Plicamycin
|
DCFQJ0R
|
Plicamycin
|
Glioma (Cell Line: SF-295)
|
[3] |
|
Triapine + Plicamycin
|
DCD6281
|
Plicamycin
|
Glioma (Cell Line: SF-539)
|
[3] |
|
Triapine + Plicamycin
|
DC7EGTV
|
Plicamycin
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
Triapine + Plicamycin
|
DC23E9L
|
Plicamycin
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[3] |
|
Triapine + Plicamycin
|
DC71BCQ
|
Plicamycin
|
Melanoma (Cell Line: MALME-3M)
|
[3] |
|
Triapine + Dexmedetomidine
|
DCCJZNV
|
Dexmedetomidine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Topetecan
|
DCAJRO6
|
Topetecan
|
Amelanotic melanoma (Cell Line: M14)
|
[3] |
|
Triapine + Pralatrexate
|
DC9LHB9
|
Pralatrexate
|
Adenocarcinoma (Cell Line: DU-145)
|
[3] |
|
Triapine + Pralatrexate
|
DCDQ46O
|
Pralatrexate
|
Adenocarcinoma (Cell Line: HCT-15)
|
[3] |
|
Triapine + Pralatrexate
|
DC2IEP5
|
Pralatrexate
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[3] |
|
Triapine + Pralatrexate
|
DCQWRIK
|
Pralatrexate
|
Glioblastoma (Cell Line: SNB-75)
|
[3] |
|
Triapine + Pralatrexate
|
DCIPBR6
|
Pralatrexate
|
Glioma (Cell Line: SF-539)
|
[3] |
|
Triapine + Pralatrexate
|
DCS0QFV
|
Pralatrexate
|
Melanoma (Cell Line: SK-MEL-2)
|
[3] |
|
Triapine + Isosorbide dinitrate
|
DCE9Y13
|
Isosorbide dinitrate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Buspirone
|
DCH1W00
|
Buspirone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Testosterone cypionate
|
DCRRDOV
|
Testosterone cypionate
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Terameprocol
|
DCRGSRI
|
Terameprocol
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[3] |
|
Triapine + Terameprocol
|
DC14U6X
|
Terameprocol
|
Adenocarcinoma (Cell Line: HCC-2998)
|
[3] |
|
Triapine + Terameprocol
|
DCENA0I
|
Terameprocol
|
Adenocarcinoma (Cell Line: SW-620)
|
[3] |
|
Triapine + Terameprocol
|
DCM0U5R
|
Terameprocol
|
Glioma (Cell Line: SF-539)
|
[3] |
|
Triapine + Terameprocol
|
DCAXD3H
|
Terameprocol
|
Glioma (Cell Line: SF-268)
|
[3] |
|
Triapine + Terameprocol
|
DCWKNSF
|
Terameprocol
|
Papillary renal cell carcinoma (Cell Line: ACHN)
|
[3] |
|
Triapine + Guanfacine
|
DCXKU4D
|
Guanfacine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Ifosfamide
|
DCRXUX4
|
Ifosfamide
|
Astrocytoma (Cell Line: U251)
|
[3] |
|
Triapine + Ifosfamide
|
DC6YFG1
|
Ifosfamide
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[3] |
|
Triapine + Ifosfamide
|
DCHR16N
|
Ifosfamide
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[3] |
|
Triapine + Ifosfamide
|
DCX2R4J
|
Ifosfamide
|
Glioma (Cell Line: SF-295)
|
[3] |
|
Triapine + Ifosfamide
|
DCWYDS5
|
Ifosfamide
|
Malignant melanoma (Cell Line: UACC62)
|
[3] |
|
Triapine + Chlorzoxazone
|
DCF01SR
|
Chlorzoxazone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + K-134
|
DC9EO6I
|
K-134
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Memantine
|
DC809R2
|
Memantine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Raloxifene
|
DCDE6SL
|
Raloxifene
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[3] |
|
Triapine + Raloxifene
|
DCL50BP
|
Raloxifene
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[3] |
|
Triapine + Raloxifene
|
DC2QIRL
|
Raloxifene
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)
|
[3] |
|
Triapine + Raloxifene
|
DCX67D4
|
Raloxifene
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[3] |
|
Triapine + ETHISTERONE
|
DCUA2DL
|
ETHISTERONE
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Galantamine
|
DCA12EI
|
Galantamine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Sulfinpyrazone
|
DC65B6L
|
Sulfinpyrazone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Nizatidine
|
DCU7TMP
|
Nizatidine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Zaleplon
|
DCTTEZ2
|
Zaleplon
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Sirolimus
|
DCR6XHE
|
Sirolimus
|
Lung adenocarcinoma (Cell Line: MDA-MB-231)
|
[3] |
|
Triapine + PHA-739358
|
DCQXO1D
|
PHA-739358
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Mitomycin
|
DC1ICYR
|
Mitomycin
|
Adenocarcinoma (Cell Line: HT29)
|
[3] |
|
Triapine + Mitomycin
|
DCVFF1P
|
Mitomycin
|
Astrocytoma (Cell Line: U251)
|
[3] |
|
Triapine + Mitomycin
|
DC0QHRJ
|
Mitomycin
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[3] |
|
Triapine + Mitomycin
|
DC3IXCW
|
Mitomycin
|
Clear cell renal cell carcinoma (Cell Line: CAKI-1)
|
[3] |
|
Triapine + Mitomycin
|
DCO46N6
|
Mitomycin
|
Lung adenocarcinoma (Cell Line: NCI-H522)
|
[3] |
|
Triapine + Mitomycin
|
DCAPN49
|
Mitomycin
|
Melanoma (Cell Line: MALME-3M)
|
[3] |
|
Triapine + Naringenin
|
DCINKDW
|
Naringenin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Pentamidine
|
DCFW9O8
|
Pentamidine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Tolazoline
|
DCN38KU
|
Tolazoline
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + PFK-158
|
DCOL80W
|
PFK-158
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Triflupromazine
|
DCGQUYA
|
Triflupromazine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Trazodone
|
DCLC8TD
|
Trazodone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Altretamine
|
DCTMAH8
|
Altretamine
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[3] |
|
Triapine + Altretamine
|
DCK6ZLP
|
Altretamine
|
Amelanotic melanoma (Cell Line: M14)
|
[3] |
|
Triapine + Altretamine
|
DC73BQ1
|
Altretamine
|
Glioma (Cell Line: SF-268)
|
[3] |
|
Triapine + Altretamine
|
DCHG6VC
|
Altretamine
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[3] |
|
Triapine + Altretamine
|
DCGIODI
|
Altretamine
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[3] |
|
Triapine + Diazoxide
|
DCV851Q
|
Diazoxide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Allopurinol
|
DC8MUW5
|
Allopurinol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Benserazide
|
DCP04L2
|
Benserazide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Idarubicin
|
DCFG4I5
|
Idarubicin
|
Glioblastoma? (Cell Line: T98G)
|
[3] |
|
Triapine + Probenecid
|
DCENJT6
|
Probenecid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Bortezomib
|
DCJ3DEQ
|
Bortezomib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Bortezomib
|
DCXJV70
|
Bortezomib
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[3] |
|
Triapine + Methylene blue
|
DCYJNF1
|
Methylene blue
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Tropisetron
|
DCF7LUF
|
Tropisetron
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Moricizine
|
DC0RF5G
|
Moricizine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Valrubicin
|
DCSZIU2
|
Valrubicin
|
Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)
|
[3] |
|
Triapine + Valrubicin
|
DC8LBZ7
|
Valrubicin
|
Lung adenocarcinoma (Cell Line: MDA-MB-231)
|
[3] |
|
Triapine + Cefmenoxime
|
DCO0CE6
|
Cefmenoxime
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Trimethobenzamide
|
DCEJIU9
|
Trimethobenzamide
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Ethambutol
|
DC21BYT
|
Ethambutol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Novobiocin
|
DCO5ZES
|
Novobiocin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Cisplatin
|
DCBMN8X
|
Cisplatin
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)
|
[3] |
|
Triapine + Chlorambucil
|
DC98DWD
|
Chlorambucil
|
Adenocarcinoma (Cell Line: HCT-15)
|
[3] |
|
Triapine + Chlorambucil
|
DC8XS84
|
Chlorambucil
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[3] |
|
Triapine + Chlorambucil
|
DCQ9CFI
|
Chlorambucil
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[3] |
|
Triapine + Sorafenib
|
DCUEXNP
|
Sorafenib
|
Adenocarcinoma (Cell Line: HCT-15)
|
[3] |
|
Triapine + Sorafenib
|
DCQS1NS
|
Sorafenib
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Sorafenib
|
DC4MK8Y
|
Sorafenib
|
Malignant melanoma (Cell Line: LOX IMVI)
|
[3] |
|
Triapine + ER819762
|
DCEU82O
|
ER819762
|
Glioma (Cell Line: SF-268)
|
[3] |
|
Triapine + ER819762
|
DC853SU
|
ER819762
|
High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)
|
[3] |
|
Triapine + ER819762
|
DC89WYJ
|
ER819762
|
Melanoma (Cell Line: UACC-257)
|
[3] |
|
Triapine + Hyodeoxycholic acid
|
DCO2WCL
|
Hyodeoxycholic acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Pomalidomide
|
DCG056I
|
Pomalidomide
|
Astrocytoma (Cell Line: U251)
|
[3] |
|
Triapine + Pomalidomide
|
DC21ZO9
|
Pomalidomide
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
Triapine + Vinflunine
|
DCFR6A1
|
Vinflunine
|
Astrocytoma (Cell Line: SNB-19)
|
[3] |
|
Triapine + Vinflunine
|
DC6U48X
|
Vinflunine
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[3] |
|
Triapine + Vinflunine
|
DC117O9
|
Vinflunine
|
Clear cell renal cell carcinoma (Cell Line: CAKI-1)
|
[3] |
|
Triapine + Vinflunine
|
DCVVWZX
|
Vinflunine
|
Glioma (Cell Line: SF-539)
|
[3] |
|
Triapine + Vinflunine
|
DCDURCF
|
Vinflunine
|
Glioma (Cell Line: SF-295)
|
[3] |
|
Triapine + Vinflunine
|
DCCCYMK
|
Vinflunine
|
Malignant melanoma (Cell Line: UACC62)
|
[3] |
|
Triapine + Vinflunine
|
DCAQJ3P
|
Vinflunine
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[3] |
|
Triapine + Mepacrine
|
DCDYUIB
|
Mepacrine
|
Adenocarcinoma (Cell Line: HCT116)
|
[3] |
|
Triapine + Mepacrine
|
DC2NMH6
|
Mepacrine
|
Astrocytoma (Cell Line: U251)
|
[3] |
|
Triapine + Mepacrine
|
DCX4DL9
|
Mepacrine
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[3] |
|
Triapine + Fosfomycin
|
DCSAXX3
|
Fosfomycin
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Nabilone
|
DCDM6SF
|
Nabilone
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Sumatriptan
|
DCWGWLM
|
Sumatriptan
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Olmesartan medoxomil
|
DC903CR
|
Olmesartan medoxomil
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + PMID28870136-Compound-43
|
DCQ4NYV
|
PMID28870136-Compound-43
|
Amelanotic melanoma (Cell Line: MDA-MB-435)
|
[3] |
|
Triapine + PMID28870136-Compound-43
|
DCNR1X0
|
PMID28870136-Compound-43
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + PMID28870136-Compound-43
|
DC1F7UR
|
PMID28870136-Compound-43
|
Glioma (Cell Line: SF-268)
|
[3] |
|
Triapine + FORMESTANE
|
DCGOZV9
|
FORMESTANE
|
Adenocarcinoma (Cell Line: DU-145)
|
[3] |
|
Triapine + FORMESTANE
|
DCH7Y6J
|
FORMESTANE
|
Adenocarcinoma (Cell Line: OVCAR3)
|
[3] |
|
Triapine + FORMESTANE
|
DCGT1Q5
|
FORMESTANE
|
Adenocarcinoma (Cell Line: HCT116)
|
[3] |
|
Triapine + FORMESTANE
|
DC27BAA
|
FORMESTANE
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[3] |
|
Triapine + FORMESTANE
|
DCYW6TR
|
FORMESTANE
|
Astrocytoma (Cell Line: U251)
|
[3] |
|
Triapine + FORMESTANE
|
DCW8FPY
|
FORMESTANE
|
Chronic myelogenous leukemia (Cell Line: K-562)
|
[3] |
|
Triapine + FORMESTANE
|
DCYY2SG
|
FORMESTANE
|
Clear cell renal cell carcinoma (Cell Line: CAKI-1)
|
[3] |
|
Triapine + FORMESTANE
|
DCOKGQ2
|
FORMESTANE
|
Glioblastoma (Cell Line: SNB-75)
|
[3] |
|
Triapine + FORMESTANE
|
DC3RCR1
|
FORMESTANE
|
Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M)
|
[3] |
|
Triapine + Estramustine
|
DCMLS4W
|
Estramustine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Busulfan
|
DC29J1S
|
Busulfan
|
Adenocarcinoma (Cell Line: HCT-15)
|
[3] |
|
Triapine + Busulfan
|
DCT8OP2
|
Busulfan
|
Astrocytoma (Cell Line: U251)
|
[3] |
|
Triapine + Busulfan
|
DCPPO5A
|
Busulfan
|
Glioma (Cell Line: SF-539)
|
[3] |
|
Triapine + Busulfan
|
DC0VNWG
|
Busulfan
|
Glioma (Cell Line: SF-268)
|
[3] |
|
Triapine + Busulfan
|
DC1E2Q6
|
Busulfan
|
Lung adenocarcinoma (Cell Line: MDA-MB-231)
|
[3] |
|
Triapine + Busulfan
|
DCW0OZI
|
Busulfan
|
Lung adenocarcinoma (Cell Line: HOP-62)
|
[3] |
|
Triapine + Hydroxychloroquine
|
DC5292I
|
Hydroxychloroquine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + ML323
|
DCY9MHO
|
ML323
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Aciclovir
|
DCTMF6K
|
Aciclovir
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Cytarabine
|
DCRVFUN
|
Cytarabine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + Cilostazol
|
DCHLQO4
|
Cilostazol
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Triapine + L-165041
|
DC493L7
|
L-165041
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[3] |
|
Trifluridine + Triapine
|
DC17SMO
|
Trifluridine
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[2] |
|
Trifluridine + Triapine
|
DCFGQVO
|
Trifluridine
|
Clear cell renal cell carcinoma (Cell Line: TK-10)
|
[2] |
|
Trifluridine + Triapine
|
DCJ7SY2
|
Trifluridine
|
Clear cell renal cell carcinoma (Cell Line: A498)
|
[2] |
|
Trifluridine + Triapine
|
DC5VSL8
|
Trifluridine
|
Breast adenocarcinoma (Cell Line: MDA-MB-468)
|
[4] |
|
Trifluridine + Triapine
|
DCJ1ZEV
|
Trifluridine
|
Adenocarcinoma (Cell Line: A549)
|
[3] |
|
Trifluridine + Triapine
|
DCVE9FB
|
Trifluridine
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)
|
[3] |
|
Trifluridine + Triapine
|
DCSSGRY
|
Trifluridine
|
Large cell lung carcinoma (Cell Line: NCI-H460)
|
[3] |
|
Trifluridine + Triapine
|
DCPHD7Z
|
Trifluridine
|
Lung adenocarcinoma (Cell Line: EKVX)
|
[3] |
|
Trifluridine + Triapine
|
DCLA67N
|
Trifluridine
|
Non-small cell lung carcinoma (Cell Line: HOP-92)
|
[3] |
|
Trifluridine + Triapine
|
DC2ZJRH
|
Trifluridine
|
Prostate carcinoma (Cell Line: PC-3)
|
[3] |
|
Triiodothyronine + Triapine
|
DCX82UD
|
Triiodothyronine
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Uracil mustard + Triapine
|
DC5TFG6
|
Uracil mustard
|
Anaplastic large cell lymphoma (Cell Line: SR)
|
[2] |
|
Uracil mustard + Triapine
|
DCRTOH8
|
Uracil mustard
|
Astrocytoma (Cell Line: SNB-19)
|
[2] |
|
Uracil mustard + Triapine
|
DCTENRU
|
Uracil mustard
|
Plasma cell myeloma (Cell Line: RPMI-8226)
|
[2] |
|
Uracil mustard + Triapine
|
DCT1FMA
|
Uracil mustard
|
Lung adenocarcinoma (Cell Line: NCI-H522)
|
[3] |
|
Valproic Acid + Triapine
|
DCYCUR3
|
Valproic Acid
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
|
Vandetanib + Triapine
|
DC54MHH
|
Vandetanib
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
Vandetanib + Triapine
|
DCMQLV9
|
Vandetanib
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[4] |
|
Vandetanib + Triapine
|
DCHAGX9
|
Vandetanib
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[3] |
|
Vandetanib + Triapine
|
DCC06QY
|
Vandetanib
|
Amelanotic melanoma (Cell Line: M14)
|
[3] |
|
Vandetanib + Triapine
|
DCGJLBZ
|
Vandetanib
|
Cutaneous melanoma (Cell Line: SK-MEL-5)
|
[3] |
|
Vandetanib + Triapine
|
DC1EUX8
|
Vandetanib
|
Glioma (Cell Line: SF-268)
|
[3] |
|
Vandetanib + Triapine
|
DC9V67R
|
Vandetanib
|
Melanoma (Cell Line: SK-MEL-2)
|
[3] |
|
Vemurafenib + Triapine
|
DCGWQH0
|
Vemurafenib
|
Adenocarcinoma (Cell Line: DU-145)
|
[3] |
|
Vemurafenib + Triapine
|
DC03RU3
|
Vemurafenib
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[3] |
|
Vemurafenib + Triapine
|
DCWSQQK
|
Vemurafenib
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)
|
[3] |
|
Vincristine + Triapine
|
DC7X4AM
|
Vincristine
|
Adenocarcinoma (Cell Line: HT29)
|
[2] |
|
Vincristine + Triapine
|
DCVR0VB
|
Vincristine
|
Clear cell renal cell carcinoma (Cell Line: 786-0)
|
[2] |
|
Vincristine + Triapine
|
DCTJOY9
|
Vincristine
|
High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)
|
[2] |
|
Vincristine + Triapine
|
DCN11HC
|
Vincristine
|
Non-small cell lung carcinoma (Cell Line: HOP-92)
|
[2] |
|
Vincristine + Triapine
|
DCPY5U0
|
Vincristine
|
Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)
|
[2] |
|
Vincristine + Triapine
|
DC3YUU2
|
Vincristine
|
Invasive ductal carcinoma (Cell Line: BT-549)
|
[4] |
|
Vismodegib + Triapine
|
DC83WFG
|
Vismodegib
|
Invasive ductal carcinoma (Cell Line: HS 578T)
|
[4] |
|
Vismodegib + Triapine
|
DCI7NQA
|
Vismodegib
|
Adult acute myeloid leukemia (Cell Line: HL-60(TB))
|
[3] |
|
Vismodegib + Triapine
|
DC37DG0
|
Vismodegib
|
Astrocytoma (Cell Line: SNB-19)
|
[3] |
|
Vismodegib + Triapine
|
DCMDSSI
|
Vismodegib
|
Melanoma (Cell Line: SK-MEL-2)
|
[3] |
|
VR-776 + Triapine
|
DC1X5Y5
|
VR-776
|
Chronic myelogenous leukemia (Cell Line: KBM-7)
|
[2] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
